The Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment (CANS-MCI), a computer administered, scored, and interpreted touch screen battery was evaluated for its ability to detect mild cognitive impairment. Subjects were three hundred ten community-dwelling elders who enrolled in an National Institute on Aging (NIA)-funded study. One-month test-retest reliability correlations were all significant (pϽ0.05-pϽ0.001). Concurrent validity correlations were all significant (pϽ0.001). A high level of diagnostic validity was attained relative to the Weschler Memory Scale-Revised (WMS-R) LMS-II test (pϽ0.001). Confirmatory factor analysis supported a three-factor model indicating the tests
S ince most new research and treatments for dementia focus on slowing the progression of Alzheimer's disease (AD), 1, 2 it is critical to identify the need for intensive diagnostic evaluation so that early treatment can delay its progression. 3, 4 People with mild cognitive impairment (MCI), characterized by marked memory impairment without disorientation, confusion, or abnormal general cognitive functioning appear to develop AD at a rate of 10%-15% a year. [5] [6] [7] Research concerning MCI, both as a distinct diagnostic entity and as a precursor to AD, [6] [7] [8] [9] [10] [11] suggests that instruments focused upon MCI measurement would provide useful screening information for decisions concerning full diagnostic evaluations for AD. Brief or automated neuropsychological tests may be the preliminary step most suited to determine the need for evaluations, which require costly neuropsychological, biochemical, or neuroimaging techniques. 12 While memory deficits have been found to be the most reliable single predictor, 5,10,13-15 studies indicate that tests sampling different cognitive domains, when combined, significantly enhance the predictive validity of a test battery because of variations in the initial cognitive deficits associated with AD. [15] [16] [17] [18] [19] Current methods 
METHODS

Subjects
A community sample of 310 elderly people was recruited through senior centers, American Legion halls, and retirement homes in four counties of Washington State. Exclusionary criteria were non-English language, significant hand tremor, inability to sustain a seated position for 45 minutes, recent surgery, cognitive side effects of drugs, indications of recent alcohol abuse, or inadequacies in visual acuity, reading ability, hearing, or dominant hand agility. The subjects were predominantly Caucasian (86%), female (65%), and had at least some college education (76%). Subject age ranged from 51-93 years, with the majority between 60-80 years of age (63%).
Neuropsychological Measures
The CANS-MCI tests were based upon the cognitive domains found to be predictive of AD in previous neuropsychological research: visuospatial ability and spatial fluency; 4, 15, 17, [20] [21] [22] executive mental control; 1, 23, 24 immediate and delayed recall; 4, 5, [13] [14] [15] 17, 18, [20] [21] [22] [23] [24] [25] [26] [27] and language fluency 4, 5, 17, 18, [20] [21] [22] 25, 27 (Table 1 ). The usability of the CANS-MCI has been previously evaluated. 28 It can be fully self-administered, regardless of computer experience, even by elderly people with MCI. It does not cause significant anxiety-based cognitive interference during testing. After a researcher enters a subject identification and adjusts the volume, the tests, including any assistance needed, are administered by a computer with external speakers and a touch screen.
The CANS-MCI was developed to include tests designed to measure executive function, language fluency, and memory (Table 1 ). The executive function tests sample two cognitive abilities: mental control and spatial abilities. Mental control is measured with a Stroop test (on which the user matches the ink color of word names rather than the name itself). Spatial abilities were tested with: a general reaction time test with minimal cognitive complexity (on which the user touches ascending numbers presented on a jumbled display; design-letter matching; word-to-picture matching; and a clock hand placement test (touching the hour and minute positions for a series of digital times). Memory for 20 object names was measured with an immediate and a delayed free and guided recognition test. Language fluency is tested with a picture naming test (on which pictures are each presented with four 2-letter word beginnings).
Unless specifically described as latency measures, the CANS-MCI and conventional neuropsychological tests in this study measure response accuracy. All latency and accuracy measures on the CANS-MCI are scalable scores.
The following conventional neuropsychological tests were used to assess the validity of the CANS-MCI tests: Weschler Memory Scale-Revised (WMS-R) Logical Memory Immediate and Delayed (LMS-I and LMS-II); 29 Mattis Dementia Rating Scale (DRS); 30 and Weschler Adult Intelligence Scale, Digit Symbol test. 31 LMS-II scores were used to classify participants as having normal cognitive functioning or MCI. The LMS-II has previously been found to differentiate normal from impaired cognitive functioning. 4, 5, 17 Procedures Each testing session lasted approximately 1 hour. The progression of tests was designed to minimize intertest th percentile based on their LMS-II scores. We conducted exploratory and confirmatory factor analyses on different subsets of data to establish whether our tests measure the expected cognitive domains.
RESULTS
Reliability
Internal consistency was examined (Table 2) using Cronbach's Coefficient alpha reliabilities to determine the degree to which individual test items correlate with one another. Only two test scores (Free Recognition II and Guidance Recognition I Percent Correct) did not meet the predetermined standard for internal consistency (␣ Ͼ.70). When the Free Recognition II score was combined with the Free Recognition I score, the combination had very high reliability ‫.)39.0ס␣(‬ Correlations measuring the stability of the CANS-MCI over a 1-month period ranged from 0.61-0.85 (Table 3). The Free Recognition I and II tests had coefficient alphas below 0.70. When these tests were combined to form a more global memory measure the alpha was acceptable ‫,)47.0ס␣(‬ therefore, they were included in further analyses. Six-month test-retest reliabilities ranged from 0.62-0.89; 9 of the 12 scores demonstrated higher 6-month reliabilities than 1-month reliabilities. One of the two measures of guidance effectiveness (Guidance Percent Correct) had low internal consistency and testretest alphas (1-month and 6-month) and therefore was not included in further analyses. Separate analyses indicated little relationship to education level on either internal consistency or test-retest reliability of the measures. All Time 2 test scores were significantly better than Time 1 scores but scores remained stable from times 2 to 3. When subjects were already familiar with the testing procedures, test scores on the CANS-MCI demonstrated markedly higher score stability over 6 months than they did over the initial 1-month period. This was confirmed by t test analyses that showed significant improvements in all scores from Time 1 to Time 2 but no significant differences from Time 2 to Time 3.
Validity
The concurrent validity of the CANS-MCI was evaluated by examining the correlations of the CANS-MCI 
Diagnostic Validation
T tests were performed to analyze differences between memory-impaired and unimpaired groups. Though Free Recognition I and II scales individually have moderate reliabilities, they were separated in the t tests because we hypothesized that they might measure different aspects of a cognitive function. Highly significant differences were observed between the memory intact group and the memory-impaired group on all CANS-MCI tests. A significant difference in age and education between groups was also observed (Table 5) .
Factor Analysis
Confirmatory factor analysis supported the highly correlated three-factor model (memory, language/spatial fluency, and executive function/mental control) found in the exploratory analysis (data not shown) indicating the tests measure the intended cognitive dimensions ( Table 6 ). The factor loadings in the confirmatory analysis were all significant and ranged from 0. 
Discussion
The results of these initial analyses indicate the CANS-MCI is a user-friendly, reliable, and valid instrument that measures several cognitive domains. The CANS-MCI computer interactions were designed to provide a high degree of self-administration usability. Our results indicate high internal reliability and high test-retest reliability comparable to other validated instruments. [30] [31] [32] [33] One score, Guidance Percent Correct, was not highly reliable and therefore was not included in further analyses. The test scores are all more consistent from Time 2 to Time 3 than they were from Time 1 to Time 2, as demonstrated by the t-scores. Even memory tests are more stable once subjects are familiar with the tests, despite the much longer time interval. All CANS-MCI test scores improve with one previous exposure, which indicates that familiarity with the testing procedures appears to make test results more dependable. It would be advisable to have a patient take the test once for practice and use the second testing as the baseline measure. Recommendations for more extensive evaluation should be based upon multiple testing sessions, at least several months apart. The CANS-MCI subtests correlate with the LMS-I & II, Digit Symbol and DRS highly enough to demonstrate concurrent validity. However, the moderate correlations indicate some differences, which might be attributed to the different ranges of ability the tests were designed to measure. For example, the DRS Initiation Scale is less discriminating at higher ability levels 30 than are the CANS-MCI Clock Hand Placement and Picture Naming tests with which is it best correlated; 42% of the subjects obtained a perfect DRS Initiation score, while 4.8% and .5% received perfect scores on the Clock Hand Placement and Naming Accuracy tests, respectively. The LMS-II is less discriminating than the CANS-MCI Free Recognition II score at the lower levels of functioning; 20 (7%) subjects received a LMS-II score of 0 and 1 (0.4%) of the subjects received the lowest score on the Free Recognition II. On the other hand, the LMS-II appears to be more discriminating at the higher levels of functioning. No subjects received a perfect LMS-II score, while 19% of subjects got the highest score possible on Free Recognition II. The CANS-MCI Free Recognition II test is substantially different from the LMS-II free recall test because free recall without prompting (used in the LMS-II) is more difficult than guided recall. Like other tests that guide learning, 34 the CANS-MCI Free Recognition test may enhance "deep semantic processing," 13 allowing trace memories to improve its scores while not improving test scores on unprompted recall. 35 Diagnostic validity is an important criterion for cognitive screening effectiveness. T tests based upon the LMS-II diagnostic criterion show that the CANS-MCI tests differentiate between the memory-impaired and unimpaired elderly. Although the reference measure (LMS-II) is a limited criterion of diagnostic validity, the corresponding differences on all the CANS-MCI tests suggest that the CANS-MCI has enough diagnostic validity to pursue more extensive analyses. The CANS-MCI also measures changes over time, a feature that seems likely to enhance its validity when assessing highly educated people who have greater cognitive reserve. Given that reserve capacity can mask the progression of AD, 36 comparisons of highly educated persons against their own previous scores might detect the insidious progression of predementia changes long before the diagnosis of MCI or AD would otherwise be reached. The extent to which sensitivity/specificity and longitudinal analyses confirm this dimension of validity is currently being studied, using full neuropsychological evaluations as the criterion standard.
The factor analyses indicated that CANS-MCI tests load onto three main factors: memory, language/spatial fluency, and executive function/mental control. These factors are similar to the three aspects of cognitive performance measured by the Consortium to Establish a Registry for Alzheimer's disease (CERAD) test batteries. 37 The CANS-MCI, LMS and DRS tests that measure the immediate acquisition or delayed retention abilities load onto Memory. Language/spatial fluency has many tests that measure the retrieval from semantic memory of words (or in the case of the Clock Hand Placement Test, spatial representation of numbers). The General Reaction Time, Design Matching, Word-to-Picture Matching, Stroop (Discordant Latency), and the Digit Symbol tests make up the Executive Function/Mental Control factor which appears to represent rapid attention switching and mental control. The memory, language/spatial fluency, and executive function/mental control factors were highly correlated, as would be expected of cognitive functions all associated with MCI and/or AD. Even though highly correlated, they appear to be distinct factors.
The Clock Hand Placement test was not part of the executive function/mental control factor as hypothesized, though in pairwise analyses (Table 4 ) the test had the highest correlation with the Digit Symbol Test--a conventional measure of several executive functioning abilities that is highly predictive of AD. 21 However, the Clock Hand Placement test also correlated moderately with the DRS Initiation Scale (r‫,)734.0ס‬ a scale that involves the naming of items in a grocery store. Both the Clock Hand Placement and DRS Initiation tests involve mental visualization translated into a response, and both load on the language/spatial fluency factor. The test that most heavily loads on language/spatial fluency (picture naming) also requires visualization of an answer before making a response.
Computerized tests have several advantages. By con-
SELF-ADMINISTERED SCREENING FOR COGNITIVE IMPAIRMENT
sistent administration and scoring, they have the ability to reduce examiner administration and scoring error, 12, 38 as well as reduce the influence of the examiner on patient response. 33 Because such tests are self-administered and no training is required to administer them, they take little staff time. Other cognitive screening tests, both brief and computerized, still take significant amounts of staff time to administer and score. Medications for stalling memory decay are being widely used and are expected to be most effective when started early in the course of dementia. Therefore, it will become increasingly important to identify cognitive impairment early in the process of decline. 3, 4, 39 The CANS-MCI is also amenable to translation with automated replacement of text, pictures, and audio segments based upon choice of a language and a specific location (e.g., English/England) at the beginning of the testing program. The CANS-MCI was created for U.S. English speakers and versions have not yet been validated for other populations.
There are several limitations to the study. A community sample increases the chance of false positives because of the low incidence of impairment in the population as compared to a clinical sample. 40 There may also be a selection bias in our sample since participants were volunteers with high levels of education.
The ability of the CANS-MCI to discriminate between individuals with and without MCI has not yet been adequately compared with findings of a criterion standard such as an independent neuropsychological battery. We do not yet know what combination of tests and scores have the most sensitivity and specificity in predicting the presence of MCI. The next step in our research is to determine this using a full neuropsychological battery as the criterion standard. Further, we will look at what amount of change over time is significant enough to warrant a recommendation for comprehensive professional testing. The CANS-MCI is a promising tool for low-cost, objective clinical screening. Further validation research is under way to determine if its longitudinal use may indicate the presence or absence of cognitive impairment well enough to guide clinician decisions about the need for a complete diagnostic evaluation.
